Guggenheim Assumes Overstock.com at Neutral
Guggenheim analyst Steven Forbes assumes Overstock.com (NASDAQ:OSTK) with a Neutral rating.
Guggenheim Assumes Etsy at Buy, Announces Price Target of $105
Guggenheim analyst Steven Forbes assumes Etsy (NASDAQ:ETSY) with a Buy rating and announces Price Target of $105.
Barrington Research Initiates Coverage On DHI Group with Outperform Rating, Announces Price Target of $12
Barrington Research analyst Gary Prestopino initiates coverage on DHI Group (NYSE:DHX) with a Outperform rating and announces Price Target of $12.
Wells Fargo Assumes Zymeworks at Overweight, Lowers Price Target of $9
Wells Fargo analyst Nick Abbott assumes Zymeworks (NYSE:ZYME) with a Overweight rating and lowers Price Target of $9.
RBC Capital Initiates Coverage On TD Synnex with Sector Perform Rating, Announces Price Target of $95
RBC Capital analyst Ashish Sabadra initiates coverage on TD Synnex (NYSE:SNX) with a Sector Perform rating and announces Price Target of $95.
Morgan Stanley Initiates Coverage On Ginkgo Bioworks Holdings with Equal-Weight Rating, Announces Price Target of $5
Morgan Stanley analyst Tejas Savant initiates coverage on Ginkgo Bioworks Holdings (NYSE:DNA) with a Equal-Weight rating and announces Price Target of $5.
B. Riley Securities Initiates Coverage On Hyperfine with Buy Rating, Announces Price Target of $3.5
B. Riley Securities analyst Neil Chatterji initiates coverage on Hyperfine (NASDAQ:HYPR) with a Buy rating and announces Price Target of $3.5.
Jefferies Initiates Coverage On Inotiv with Buy Rating, Announces Price Target of $27
Jefferies analyst David Windley initiates coverage on Inotiv (NASDAQ:NOTV) with a Buy rating and announces Price Target of $27.
Needham Initiates Coverage On Glaukos with Buy Rating, Announces Price Target of $66
Needham analyst David Saxon initiates coverage on Glaukos (NYSE:GKOS) with a Buy rating and announces Price Target of $66.
Needham Initiates Coverage On Sight Sciences with Hold Rating
Needham analyst David Saxon initiates coverage on Sight Sciences (NASDAQ:SGHT) with a Hold rating.